Status | Study |
Completed |
Study Name: A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults. Condition: Shigellosis Date: 2013-12-17 Interventions: Biological: S. sonnei 1790GAHB |
Completed |
Study Name: Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults Condition: Shigellosis Date: 2012-01-05 Interventions: Biological: Shigella flexneri 2a whole cell killed vaccine (Sf2aWC) |
Completed |
Study Name: Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP Condition: Shigella Date: 2011-10-26 Interventions: Biological: CVD 1208S, a Shigella flexneri 2a live, oral vaccine |
Withdrawn |
Study Name: Shigella Sonnei OSPC-rDT Conjugate Vaccine Condition: Shigellosis Date: 2011-07-20 Interventions: Drug: CP Immunization |
Completed |
Study Name: Shigella Sonnel O-SPC/rBRU Conjugate Vaccine Condition: Immunogenicity Shigellosis Date: 2011-06-08 Interventions: Biological: Shigella Sonnei O-SPC/rBRU |
Completed |
Study Name: Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3 Condition: Shigella Infection Date: 2011-04-14 Interventions: Biological: WRSs2 WRSs2 is a l |
Completed |
Study Name: Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella Condition: Shigellosis Date: 2010-02-15 Interventions: Biological: Shigella vaccine Two intramuscular injections of bioconjugate vaccine will be administrated |
Completed |
Study Name: Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate Condition: Dysentery Shigella Diarrhea Date: 2009-12-23 Interventions: Biological: WRSS1 vaccine Sing |
Terminated |
Study Name: Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb Condition: Shigella Date: 2009-03-19 Interventions: Biological: CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a The challenge strain consists |
Terminated |
Study Name: Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa Condition: Shigella Date: 2009-03-19 Interventions: Biological: CVD 1208S, a Shigella flexneri 2a live, oral vaccine |